Editas Medicine, Inc. · NASDAQ:EDIT
O'Neill Gilmore Neil sold 15,380 Editas Medicine, Inc. shares (Form 4)
Traded Jun 3, 2026 · Filed Jun 5, 2026
On Jun 3, 2026, O'Neill Gilmore Neil (Director, CEO) sold 15,380 Editas Medicine, Inc. shares at US$2.70 for US$41,526 under a trading plan, leaving 248,313 shares. Filed Jun 5, 2026 (Form 4).
- Sold
- 15,380 shares
- Price
- US$2.70
- Value
- US$41,526
- Holding after
- 248,313 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 3, 2026 | Common Stock | Sale | 15,380 | US$2.70 | 248,313 | Direct |
Source
Related
- Editas Medicine, Inc.
- O'Neill Gilmore Neil
- Editas Medicine, Inc. shareholders
- Form 4 · O'Neill Gilmore Neil · Sep 4, 2026
- Form 4 · Burkly Linda · Sep 4, 2026
- Form 4 · Parison Amy · Sep 4, 2026
- Schedule 13G · ADAR1 Capital Management, LLC · Aug 14, 2026
- Form 4 · Parison Amy · Aug 5, 2026
- Form 4 · Burkly Linda · Jul 29, 2026